Author:
Santos-Lasaosa S.,Cuadrado M.L.,Gago-Veiga A.B.,Guerrero-Peral A.L.,Irimia P.,Láinez J.M.,Leira R.,Pascual J.,Porta-Etessam J.,Sánchez del Río M.,Viguera Romero J.,Pozo-Rosich P.
Reference72 articles.
1. Migraña crónica;Guerrero,2015
2. OnabotulinumtoxinA for the treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1trial;Aurora;Cephalalgia,2010
3. OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial;Diener;Cephalalgia,2010
4. The International Classification of Headache Disorders, 3rd edition (beta version);Cephalalgia.,2013
5. Botulinum toxin type A as a therapeutic agent against headache and related disorders;Lusivetto;Toxins (Basel),2015
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献